Treatment discontinuation among users of GLP-1 receptor agonists and SGLT2 inhibitors in a national population of individuals with type 2 diabetes
Lim CE, Pasternak B, Eliasson B, Ueda P
Diabetologia. Pub. online 2 May 2025.
Leggi
Lim CE, Pasternak B, Eliasson B, Ueda P
Diabetologia. Pub. online 2 May 2025.
Leggi
Sattar N, Neeland IJ, Dahlqvist Leinhard O, et al.
Lancet Diabetes Endocrinol. Pub. online 30 Apr 2025.
Leggi
Wing S, Ray JG, Yau K, et al.
JAMA Intern Med. 2025:e250686.
Leggi
Panchal K, Lawson CA, Shabnam S, et al.
Diabetes Obes Metab. Pub. online 2 May 2025.
Leggi
Eeg-Olofsson K, Nathanson D, Spelman T, et al.
Diabetologia. Pub. online 24 Apr 2025.
Leggi
Chew BH, Ngiam KY
BMC Med. 2025;23(1):244
Leggi
Zhou J, Mychaleckyj JC, Onengut-Gumuscu S, et al.
Diabetologia. Pub. online 23 Apr 2025.
Leggi
Lee CMY, Gibson AA, Nassar N, Colagiuri S Diabetes Obes Metab. Pub. online 23 Apr 2025. Abstract e full text
Leggi
Guo L, Zhang J, An R, et al.
BMC Med. 2025;23(1):234.
Leggi
Raje S, Maiya GA, Padmakumar R, et al.
BMC Endocr Disord. 2025;25(1):117.
Leggi